arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


Disclaimer: CME certification for these activities has expired. All information is pertinent to the timeframe in which it was released.


Advances in Asthma Management


GOAL
To provide physicians with current information on new advances in the management and treatment of asthma.

TARGET AUDIENCE
This activity is designed for pulmonologists, allergists, and primary care physicians.

LEARNING OBJECTIVES
Because of tremendous advances in knowledge about the pathophysiology of asthma, health care providers are better able than ever before to tailor asthma therapy to patients' individual needs and to help patients maintain good lung function, functional ability, and quality of life. Good asthma control is an achievable goal for the vast majority of patients with asthma. This slide set was developed to bring health care providers the most current information on asthma management in an effort to ensure that they are applying new learnings about asthma and making best use of asthma therapy. Upon completion of this program, participants will be able to:

  • To review the National Heart, Lung, and Blood Institute (NHLBI) goals of asthma therapy;
  • To understand the state of asthma care in the United States with reference to the NHLBI guidelines;
  • To understand where improvement in current care for asthma is warranted;
  • To become familiar with the newest clinical data on dual-controller therapy, an NHLBI-recommended strategy for controlling moderate persistent and severe persistent asthma; and
  • To understand the best means of monitoring and preventing asthma exacerbations and the importance of monitoring and preventing exacerbations in reducing asthma-associated morbidity and mortality.

ACCREDITATION STATEMENT
This activity has been planned and produced in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this continuing medical education activity for a maximum of 1 hour in category 1 credit toward the American Medical Association Physicians' Recognition Award. Each physician should claim only those hours of credit that are actually spent on the educational activity. Credits are available until the expiration date of December 31, 2003.

This continuing medical education activity was produced under the supervision of Peter S. Creticos, MD, Associate Professor of Medicine, Johns Hopkins University School of Medicine; Clinical Director, Division of Allergy and Clinical Immunology; Medical Director, Asthma and Allergy Diseases, Johns Hopkins Asthma & Allergy Center.

This program is supported by an unrestricted educational grant from GlaxoSmithKline.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES

FACULTY MEMBER
Peter S. Creticos, MD, reports grant/research support from, serving as a consultant to, and is a member of the speakers' bureau for ALK, Allergenics, Aradigon, Aventis, AstraZeneca, Dynarax, GlaxoSmithKline, Janssen, McNeil, Merck, Pfizer, Pharmacia & Upjohn, Schering-Plough, and Stallergens.

Richard J. Martin, MD, reports receiving grant/research support from, serving as a consultant to, and receiving honorarium from GlaxoSmithKline, 3M, Aventis, Schering, Forest, Merck, AstraZeneca, Purdue, Novartis, and Immunex.

William Calhoun, MD, reports receiving grant/research support from Merck, GlaxoSmithKline, and Sepracor.

PUBLISHER'S NOTE AND DISCLAIMER
The opinions expressed in this issue are those of the authors, presenters, and/or panelists and are not attributable to the publisher, editor, advisory board of Advanced Studies in Medicine, or The Johns Hopkins University School of Medicine or its Office of Continuing Medical Education. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this issue are not necessarily the same as indicated in the package insert for the product and may reflect the clinical experience of the authors, presenters, and/or panelists or may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, LLC, an HMG Company. P.O. Box 340, Somerville, NJ 08876. (908) 253-9001. Web site: www.galenpublishing.com. Copyright ©2001 by Galen Publishing, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Bulk postage paid at Somerville, NJ Post Office and at additional mailing offices. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC. Printed on acid-free paper. BPA Membership applied for December 2000.

CHAIRPERSON

    Peter S. Creticos, MD
    Associate Professor of Medicine
    Johns Hopkins University School of Medicine
    Clinical Director, Division of Allergy and Clinical Immunology
    Medical Director, Asthma and Allergy Diseases
    Johns Hopkins Asthma and Allergy Center
    Baltimore, Maryland

FACULTY

    Richard J. Martin, MD
    Professor of Medicine
    University of Colorado
    Health Sciences Center
    Head of Pulmonary Division
    Vice Chair of the Department of Medicine
    National Jewish Medical and Research Center
    Denver, Colorado

    William Calhoun, MD
    Associate Professor of Medicine
    Director, Asthma, Allergy, and Airway Research Center
    University of Pittsburgh School of Medicine
    Pittsburgh, Pennsylvania

Advanced Studies in Medicine provides disclosure information from contributing authors, participating faculty, and presenters only. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

January 2002


Dear Colleague:

On behalf of Johns Hopkins University School of Medicine, I am pleased to present you with this continuing medical education program entitled "Advances in Asthma Management."

Because of tremendous advances in knowledge about the pathophysiology of asthma, health care providers are better able than ever before to tailor asthma therapy to patients' individual needs and to help patients maintain good lung function, functional ability, and quality of life. Good asthma control is an achievable goal for the vast majority of patients with asthma. This CD-ROM slide lecture was developed to bring you the most current information on asthma management in an effort to ensure that you have the tools to apply new learnings about asthma and to make the best use of asthma therapy. The slide lecture is accompanied by expert commentary that will help you disseminate this information to other health care providers involved in the management of patients with respiratory diseases.

The CD-ROM slide lecture reviews the National Heart, Lung, and Blood Institute (NHLBI) goals of asthma therapy; considers the state of asthma care in the United States with reference to the NHLBI guidelines; reviews the newest clinical data on dual-controller therapy, a NHLBI-recommended strategy for controlling moderate persistent and severe persistent asthma; and considers the best means of monitoring and preventing asthma exacerbations in order to reduce asthma-associated morbidity and mortality. We hope that you find the information useful in improving the quality of care for patients with asthma.


Sincerely,

Peter S. Creticos, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Clinical Director, Division of Allergy and Clinical Immunology
Medical Director, Asthma and Allergy Diseases
Johns Hopkins Asthma & Allergy Center





Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334), is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2012 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of The Healthcare Media Group, LLC.